Zydus Cadila gets nod from Mexican authority for clinical trials of COVID-19 therapy

Drug firm Zydus Cadila on Friday said it has received approval from Mexico''s regulatory authority Cofepris to conduct clinical trials in the Latin American country with its biological therapy "Pegylated Interferon alpha-2b" for treatment of COVID-19.

from IndiaTV Business: Google News Feed https://ift.tt/2CbXeVL